BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18351146)

  • 1. [Rituximab (Mabthera)--new approach in treatment of rheumatoid arthritis].
    Anić B
    Reumatizam; 2007; 54(2):72-3. PubMed ID: 18351146
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rituximab (MabThera) as treatment of active rheumatoid arthritis].
    El Fassi D; Nielsen CH; Bendtzen K
    Ugeskr Laeger; 2006 Nov; 168(47):4079-81. PubMed ID: 17134602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rituximab (MabThera)--a new biological medicine in rheumatoid arthritis therapy].
    Nemec P
    Vnitr Lek; 2007 Nov; 53(11):1199-210. PubMed ID: 18277630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rituximab (Mabthera)--treatment of rheumatoid arthritis patients with inadequate response to TNF inhibitors--when to change therapy?].
    Morović-Vergles J
    Reumatizam; 2008; 55(2):70-2. PubMed ID: 19024280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab and abatacept for rheumatoid arthritis.
    BMJ Group
    Drug Ther Bull; 2008 Aug; 46(8):57-61. PubMed ID: 18687584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rituximab: a new therapeutic arm in refractory rheumatoid arthritis: about one case].
    Abdelmoula LC; Testouri N; Ben Hadj Yahia C; Tekaya R; Ben M'barek R; Chaabouni L; Zouari R
    Tunis Med; 2008 Sep; 86(9):841-2. PubMed ID: 19472790
    [No Abstract]   [Full Text] [Related]  

  • 7. [Administration of rituximab in rheumatoid arthritis from the position of evidence-based medicine].
    Nasonov EL
    Ter Arkh; 2007; 79(12):76-82. PubMed ID: 18220039
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context.
    Soriano ER; Galarza-Maldonado C; Cardiel MH; Pons-Estel BA; Massardo L; Caballero-Uribe CV; Achurra-Castillo AF; Barile-Fabris LA; Chávez-Corrales J; Díaz-Coto JF; Esteva-Spinetti MH; Guibert-Toledano M; Palazuelos FI; Keiserman MW; Lomonte AV; Mota LM; Pineda Villaseñor C; Alarcón GS;
    Rheumatology (Oxford); 2008 Jul; 47(7):1097-9. PubMed ID: 18463144
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis.
    Hellmann M; Jung N; Owczarczyk K; Hallek M; Rubbert A
    Rheumatology (Oxford); 2008 Jun; 47(6):929-30. PubMed ID: 18411212
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab (Rituxan) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2006 Apr; 48(1233):34-5. PubMed ID: 16625143
    [No Abstract]   [Full Text] [Related]  

  • 11. A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis.
    van den Bemt BJ; Vos K; den Broeder AA; Blom M; Thurlings RM; Bartelds GM; Stapel SO; Barrera P; Tak PP; Nurmohamed MT; Wolbink GJ
    Ann Rheum Dis; 2009 Aug; 68(8):1368-9. PubMed ID: 19605744
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of rheumatoid vasculitis-associated foot drop with rituximab.
    Maher LV; Wilson JG
    Rheumatology (Oxford); 2006 Nov; 45(11):1450-1. PubMed ID: 16936329
    [No Abstract]   [Full Text] [Related]  

  • 13. Long term treatment of rheumatoid arthritis with rituximab.
    Caporali R; Caprioli M; Bobbio-Pallavicini F; Bugatti S; Montecucco C
    Autoimmun Rev; 2009 Jun; 8(7):591-4. PubMed ID: 19393205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab in rheumatoid arthritis following anti-TNF-associated tuberculosis.
    Burr ML; Malaviya AP; Gaston JH; Carmichael AJ; Ostör AJ
    Rheumatology (Oxford); 2008 May; 47(5):738-9. PubMed ID: 18375402
    [No Abstract]   [Full Text] [Related]  

  • 15. Rituximab for rheumatoid arthritis. Practical guidance for optimizing treatment.
    Furfaro N
    Adv Nurse Pract; 2008 Jan; 16(1):61-4. PubMed ID: 20014746
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate.
    Owczarczyk K; Hellmann M; Fliedner G; Röhrs T; Maizus K; Passon D; Hallek M; Rubbert A
    Ann Rheum Dis; 2008 Nov; 67(11):1648-9. PubMed ID: 18854518
    [No Abstract]   [Full Text] [Related]  

  • 17. Membranous glomerulopathy associated with rheumatoid arthritis may respond to rituximab.
    Pixley J; Wolf B; O'Neill W
    Scand J Rheumatol; 2008; 37(4):313-4. PubMed ID: 18612934
    [No Abstract]   [Full Text] [Related]  

  • 18. Costs of rituximab maintenance treatment in patients with refractory rheumatoid arthritis.
    Risselada A; Tekstra J; Teng YK; Welsing PM; Breedveld F; van Laar JM; Bijlsma JW
    Ann Rheum Dis; 2010 Oct; 69(10):1891-2. PubMed ID: 20444758
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab for rheumatoid arthritis.
    Okamoto H; Kamatani N
    N Engl J Med; 2004 Oct; 351(18):1909; author reply 1909. PubMed ID: 15509828
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritis.
    Blank N; Max R; Schiller M; Briem S; Lorenz HM
    Rheumatology (Oxford); 2009 Apr; 48(4):440-1. PubMed ID: 19153143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.